Balance Sheet HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 01:30:02 14/09/2024 am IST			5-day change	1st Jan Change
394.68 ^USD	+0.77%		+1.73%	+45.81%

12/09	Hca Healthcare Insider Sold Shares Worth $3,221,340, According to a Recent SEC Filing	MT
05/09	Transcript : HCA Healthcare, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 03:20 PM

d9029fe8f4118d76ba8fa73e6e62f.nOI9TWAaugdvaqiA8H0mqFUPqsDYa2fZ7dIX7p-VMbc.99J5DhIowzM_JZu5xzpCmiJVmZSyXQXql4JdpafGX87dpXx6NljwfjkOww

Published financial data: HCA HEALTHCARE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	51.34B	51.53B	58.75B	60.23B	64.97B
Total Revenues	51.34B	51.53B	58.75B	60.23B	64.97B
Cost of Goods Sold, Total	32.04B	32.3B	36.26B	37.06B	39.39B
Gross Profit	19.3B	19.23B	22.49B	23.18B	25.58B
Selling General & Admin Expenses, Total	855M	923M	989M	976M	994M
Depreciation & Amortization - (IS)	2.6B	2.72B	2.85B	2.97B	3.08B
Other Operating Expenses	8.63B	8.38B	8.97B	10.18B	11.88B
Other Operating Expenses, Total	12.08B	12.03B	12.81B	14.12B	15.95B
Operating Income	7.22B	7.2B	9.68B	9.05B	9.63B
Interest Expense, Total	-1.82B	-1.58B	-1.57B	-1.74B	-1.94B
Net Interest Expenses	-1.82B	-1.58B	-1.57B	-1.74B	-1.94B
Income (Loss) On Equity Invest.	43M	54M	113M	45M	22M
EBT, Excl. Unusual Items	5.44B	5.67B	8.22B	7.36B	7.71B
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	18M	-7M	1.62B	1.3B	-5M
Legal Settlements	-	-	-	-	-
Other Unusual Items	-211M	-235M	-12M	-78M	-
EBT, Incl. Unusual Items	5.24B	5.43B	9.83B	8.58B	7.71B
Income Tax Expense	1.1B	1.04B	2.11B	1.75B	1.62B
Earnings From Continuing Operations	4.14B	4.39B	7.72B	6.83B	6.09B
Net Income to Company	4.14B	4.39B	7.72B	6.83B	6.09B
Minority Interest	-640M	-633M	-765M	-1.19B	-849M
Net Income - (IS)	3.5B	3.75B	6.96B	5.64B	5.24B
Net Income to Common Incl Extra Items	3.5B	3.75B	6.96B	5.64B	5.24B
Net Income to Common Excl. Extra Items	3.5B	3.75B	6.96B	5.64B	5.24B
Per Share Items
Net EPS - Basic	10.27	11.1	21.51	19.44	19.24
Basic EPS - Continuing Operations	10.27	11.1	21.51	19.44	19.24
Basic Weighted Average Shares Outstanding	341M	338M	323M	290M	272M
Net EPS - Diluted	10.07	10.93	21.16	19.15	18.97
Diluted EPS - Continuing Operations	10.07	10.93	21.16	19.15	18.97
Diluted Weighted Average Shares Outstanding	348M	344M	329M	295M	276M
Normalized Basic EPS	8.08	8.61	13.53	11.73	14.58
Normalized Diluted EPS	7.92	8.47	13.31	11.56	14.36
Dividend Per Share	1.6	0.43	1.92	2.24	2.4
Payout Ratio	15.69	4.08	8.97	11.57	12.61
American Depositary Receipts Ratio (ADR)	0.05	0.05	0.05	0.05	0.05
Supplemental Items
EBITDA	9.81B	9.92B	12.53B	12.02B	12.7B
EBITA	7.23B	7.23B	9.7B	9.1B	9.65B
EBIT	7.22B	7.2B	9.68B	9.05B	9.63B
EBITDAR	10.67B	10.85B	13.52B	13B	13.7B
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	20.96	19.21	21.48	20.35	20.96
Current Domestic Taxes	804M	1.15B	2.08B	1.43B	1.33B
Current Foreign Taxes	17M	5M	15M	18M	3M
Total Current Taxes	821M	1.15B	2.1B	1.45B	1.33B
Deferred Domestic Taxes	283M	-112M	6M	288M	262M
Deferred Foreign Taxes	-5M	3M	11M	12M	19M
Total Deferred Taxes	278M	-109M	17M	300M	281M
Normalized Net Income	2.76B	2.91B	4.38B	3.41B	3.97B
Interest on Long-Term Debt	1.82B	1.58B	1.57B	1.74B	1.94B
Non-Cash Pension Expense	74M	67M	64M	-16M	52M
Supplemental Operating Expense Items
Net Rental Expense, Total	855M	923M	989M	976M	994M
Imputed Operating Lease Interest Expense	364M	341M	355M	353M	376M
Imputed Operating Lease Depreciation	491M	582M	634M	623M	618M
Stock-Based Comp., COGS (Total)	347M	362M	440M	341M	262M
Total Stock-Based Compensation	347M	362M	440M	341M	262M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	621M	1.79B	1.45B	908M	935M
Short Term Investments	147M	116M	103M	92M	87M
Total Cash And Short Term Investments	768M	1.91B	1.55B	1B	1.02B
Accounts Receivable, Total	7.39B	7.06B	8.11B	8.9B	9.97B
Total Receivables	7.39B	7.06B	8.11B	8.9B	9.97B
Inventory	1.85B	2.02B	1.99B	2.07B	2.02B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	1.19B	1.34B	1.9B	1.67B	1.92B
Total Current Assets	11.2B	12.33B	13.54B	13.64B	14.93B
Gross Property Plant And Equipment	49.07B	51.34B	53.46B	56.82B	60.76B
Accumulated Depreciation	-24.52B	-26.12B	-27.29B	-29.18B	-30.83B
Net Property Plant And Equipment	24.55B	25.22B	26.18B	27.64B	29.92B
Long-term Investments	564M	810M	886M	1.2B	1.23B
Goodwill	7.94B	8.21B	9.14B	9.29B	9.61B
Other Intangibles, Total	330M	369M	403M	359M	339M
Accounts Receivable Long-Term	37M	31M	44M	48M	34M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	443M	515M	554M	250M	150M
Total Assets	45.06B	47.49B	50.74B	52.44B	56.21B
Liabilities
Accounts Payable, Total	2.9B	3.54B	4.11B	4.24B	4.23B
Accrued Expenses, Total	3.9B	4.02B	4.25B	4.33B	5.1B
Current Portion of Long-Term Debt	58M	81M	102M	239M	2.26B
Current Portion of Leases	437M	507M	535M	495M	529M
Other Current Liabilities	457M	560M	587M	596M	532M
Total Current Liabilities	7.76B	8.7B	9.58B	9.9B	12.66B
Long-Term Debt	33.11B	30.35B	33.76B	37.14B	36.63B
Long-Term Leases	1.97B	2.17B	2.33B	2.33B	2.44B
Other Non Current Liabilities	2.78B	3.38B	3.57B	3.14B	3.42B
Total Liabilities	45.62B	44.6B	49.25B	52.51B	55.15B
Common Stock, Total	3M	3M	3M	3M	3M
Additional Paid In Capital	-	294M	-	-	-
Retained Earnings	-2.35B	777M	-532M	-2.28B	-1.35B
Comprehensive Income and Other	-460M	-502M	-404M	-490M	-425M
Total Common Equity	-2.81B	572M	-933M	-2.77B	-1.77B
Minority Interest	2.24B	2.32B	2.42B	2.69B	2.83B
Total Equity	-565M	2.89B	1.49B	-73M	1.06B
Total Liabilities And Equity	45.06B	47.49B	50.74B	52.44B	56.21B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	338M	340M	304M	277M	264M
ECS Total Common Shares Outstanding	338M	339M	305M	277M	266M
Book Value / Share	-8.3	1.69	-3.05	-9.98	-6.68
Tangible Book Value	-11.08B	-8.01B	-10.47B	-12.42B	-11.72B
Tangible Book Value Per Share	-32.73	-23.59	-34.28	-44.78	-44.13
Total Debt	35.58B	33.1B	36.73B	40.2B	41.86B
Net Debt	34.81B	31.19B	35.18B	39.2B	40.84B
Debt Equivalent of Unfunded Proj. Benefit Obligation	419M	446M	459M	347M	333M
Debt Equivalent Oper. Leases	6.84B	7.38B	7.91B	7.81B	7.95B
Minority Interest, Total (Incl. Fin. Div)	2.24B	2.32B	2.42B	2.69B	2.83B
Equity Method Investments, Total	249M	422M	448M	823M	756M
Account Code - Inventory Valuation	5	5	5	5	5
Land - (BS)	2.18B	2.27B	2.5B	2.8B	3.12B
Buildings, Total	17.67B	18.47B	19.21B	20.22B	21.56B
Machinery, Total	25.76B	27.08B	28.26B	29.98B	32B
Full Time Employees	210K	195K	204K	207K	220K
Part Time Employees	70K	80K	80K	87K	90K
Accumulated Allowance for Doubtful Accounts (Supple)	6.95B	6.11B	6.78B	6.78B	7.28B

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	3.5B	3.75B	6.96B	5.64B	5.24B
Depreciation & Amortization - CF	2.58B	2.7B	2.83B	2.92B	3.06B
Amortization of Goodwill and Intangible Assets - (CF)	12M	26M	25M	44M	20M
Depreciation & Amortization, Total	2.6B	2.72B	2.85B	2.97B	3.08B
Amortization of Deferred Charges, Total - (CF)	30M	30M	27M	29M	35M
(Gain) Loss From Sale Of Asset	-18M	7M	-1.62B	-1.3B	5M
Stock-Based Compensation (CF)	347M	362M	440M	341M	262M
Other Operating Activities, Total	1.23B	1.08B	806M	1.99B	1.27B
Change In Accounts Receivable	-326M	327M	-962M	-797M	-935M
Change In Inventories	-158M	-304M	-540M	-59M	-126M
Change In Accounts Payable	396M	1.26B	999M	-296M	604M
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	7.6B	9.23B	8.96B	8.52B	9.43B
Capital Expenditure	-4.16B	-2.84B	-3.58B	-4.4B	-4.74B
Cash Acquisitions	-1.68B	-568M	-1.1B	-224M	-635M
Divestitures	61M	68M	2.16B	1.24B	193M
Investment in Marketable and Equity Securities, Total	25M	-20M	-117M	14M	-112M
Other Investing Activities, Total	34M	-38M	-4M	-21M	-19M
Cash from Investing	-5.72B	-3.39B	-2.64B	-3.39B	-5.32B
Long-Term Debt Issued, Total	6.45B	2.7B	7.12B	6.12B	3.22B
Total Debt Issued	6.45B	2.7B	7.12B	6.12B	3.22B
Long-Term Debt Repaid, Total	-5.88B	-5.92B	-3.87B	-2.83B	-1.93B
Total Debt Repaid	-5.88B	-5.92B	-3.87B	-2.83B	-1.93B
Repurchase of Common Stock	-1.03B	-441M	-8.22B	-7B	-3.81B
Common Dividends Paid	-550M	-153M	-624M	-653M	-661M
Common & Preferred Stock Dividends Paid	-550M	-153M	-624M	-653M	-661M
Other Financing Activities, Total	-757M	-866M	-1.07B	-1.29B	-917M
Cash from Financing	-1.77B	-4.68B	-6.66B	-5.66B	-4.09B
Foreign Exchange Rate Adjustments	8M	10M	-3M	-20M	7M
Net Change in Cash	119M	1.17B	-342M	-543M	27M
Supplemental Items
Cash Interest Paid	1.91B	1.61B	1.5B	1.66B	1.89B
Cash Income Tax Paid (Refund)	849M	1B	2.18B	1.18B	1.39B
Levered Free Cash Flow	1.9B	4.65B	4.08B	3.08B	2.87B
Unlevered Free Cash Flow	3.01B	5.61B	5.03B	4.14B	4.05B
Change In Net Working Capital	283M	-858M	735M	432M	562M
Net Debt Issued / Repaid	567M	-3.22B	3.26B	3.29B	1.3B

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	10.71	9.73	12.32	10.97	11.08
Return on Total Capital	13.89	12.68	16.3	14.44	14.49
Return On Equity %	-238.01	377.05	352.48	965.25	1.23K
Return on Common Equity	-90.36	-335.78	-3.85K	-305.03	-230.87
Margin Analysis
Gross Profit Margin %	37.59	37.32	38.28	38.48	39.37
SG&A Margin	1.67	1.79	1.68	1.62	1.53
EBITDA Margin %	19.12	19.26	21.33	19.96	19.55
EBITA Margin %	14.08	14.03	16.52	15.1	14.85
EBIT Margin %	14.06	13.98	16.47	15.03	14.82
Income From Continuing Operations Margin %	8.07	8.51	13.14	11.35	9.38
Net Income Margin %	6.83	7.28	11.84	9.37	8.07
Net Avail. For Common Margin %	6.83	7.28	11.84	9.37	8.07
Normalized Net Income Margin	5.37	5.65	7.45	5.66	6.11
Levered Free Cash Flow Margin	3.71	9.02	6.94	5.12	4.42
Unlevered Free Cash Flow Margin	5.87	10.88	8.56	6.88	6.23
Asset Turnover
Asset Turnover	1.22	1.11	1.2	1.17	1.2
Fixed Assets Turnover	2.32	2.07	2.29	2.24	2.26
Receivables Turnover (Average Receivables)	7.24	7.13	7.75	7.08	6.89
Inventory Turnover (Average Inventory)	17.9	16.68	18.08	18.28	19.27
Short Term Liquidity
Current Ratio	1.44	1.42	1.41	1.38	1.18
Quick Ratio	1.05	1.03	1.01	1	0.87
Operating Cash Flow to Current Liabilities	0.98	1.06	0.93	0.86	0.75
Days Sales Outstanding (Average Receivables)	50.44	51.31	47.11	51.54	53
Days Outstanding Inventory (Average Inventory)	20.4	21.95	20.19	19.97	18.95
Average Days Payable Outstanding	31.11	36.29	38.52	41.03	39.3
Cash Conversion Cycle (Average Days)	39.72	36.97	28.77	30.47	32.65
Long Term Solvency
Total Debt/Equity	-6.3K	1.14K	2.47K	-55.07K	3.95K
Total Debt / Total Capital	101.61	91.97	96.1	100.18	97.53
LT Debt/Equity	-6.21K	1.12K	2.42K	-54.06K	3.69K
Long-Term Debt / Total Capital	100.2	90.33	94.44	98.35	91.04
Total Liabilities / Total Assets	101.25	93.91	97.07	100.14	98.11
EBIT / Interest Expense	3.96	4.55	6.18